INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 155 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,448,742 | +14.4% | 123,800 | +39.1% | 0.07% | +16.1% |
| Q2 2023 | $5,635,480 | +1431.4% | 89,000 | +1026.6% | 0.06% | +785.7% |
| Q3 2022 | $368,000 | -18.4% | 7,900 | 0.0% | 0.01% | -12.5% |
| Q2 2022 | $451,000 | -52.1% | 7,900 | -48.7% | 0.01% | -27.3% |
| Q1 2022 | $942,000 | +110.7% | 15,400 | +28.3% | 0.01% | +120.0% |
| Q3 2021 | $447,000 | -43.5% | 12,000 | -76.0% | 0.01% | -86.5% |
| Q1 2020 | $791,000 | -76.9% | 50,000 | -50.0% | 0.04% | +516.7% |
| Q4 2019 | $3,431,000 | – | 100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |